MTMaocan Tao

Maocan Tao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maocan Tao has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Yi Cao

    The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)

    4 shared publications
  • Qiujun Zhou

    The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China

    3 shared publications
  • Shenyu Wei

    Department of Hepato‑Pancreato‑Biliary Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310000, P.R. China

    2 shared publications
  • Shiqian Chai

    Department of First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310000, P.R. China

    2 shared publications
  • Yi Cao

    The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine) Hangzhou China

    2 shared publications
  • Yuanyuan Li

    Department of Dermatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Province Hospital of Chinese Medicine), Hangzhou China

    2 shared publications

Latest Publications

  • Open Access

    Engineering immune-competent hair follicle microphysiological systems: from organoid assembly to dynamic immune modelling

    by Hanxiao Qu, Liudong Tong, Qinyi Lou, Lijun Qing, Maocan Tao, Hongbin Luo

    Hair follicle organoids (HF organoids) have progressed from simple epithelial–mesenchymal aggregates to spatially organized follicle-like structures and skin–hair follicle composite models. However, most current systems still focus on follicular morphogenesis and structural reconstruction, with limited capacity to recapitulate the immune, vascular, neural, and dynamic regulatory features of the native hair follicle (HF) microenvironment. This limitation is particularly relevant to immune-mediated hair disorders, such as alopecia areata, lichen planopilaris, and frontal fibrosing alopecia, in which immune privilege (IP) collapse, inflammatory infiltration, hair follicle stem cell (HFSC) niche damage, and tissue remodelling are central pathological events. In this Review, we discuss the transition from structurally oriented HF organoids towards immune-competent hair follicle microphysiological systems (HF-MPS). We summarize the structural basis of HF engineering, define immune competence as a functional state involving IP maintenance, immune-cell regulation of HF cycling and regeneration, and controllable inflammatory injury, and examine engineering strategies including local immune microenvironment control, compartmentalized culture, dynamic perfusion, vascularized and innervated interfaces, and quantitative monitoring. We further discuss applications in disease modelling, dynamic drug evaluation, patient-derived platforms, and regenerative medicine, while highlighting evidence boundaries and technical limitations. Immune-competent HF-MPS should be viewed as evolving human-relevant platforms rather than mature replacements for existing models.


  • Open Access

    Apalutamide-induced life-threatening dermatologic toxicity: Clinical histopathological correlations and salvage therapies in four cases: Case report series

    by Yuanyuan Li, Yi Cao, Lei Wei, Jingyi Zhao, Maocan Tao, Xiaoqing Zhao

    Rationale: Apalutamide is a novel next-generation oral antiandrogen receptor targeting agent for castration-resistant prostate cancer. However, it is associated with skin adverse events (AEs), which have been reported in clinical trials but are not fully understood due to limited clinical data. This case report explored the clinical presentation and management of apalutamide-associated skin events through 4 representative cases. Patient concerns: Four male patients with prostate cancer developed various skin rashes after taking apalutamide. The rashes were characterized by different manifestations, including erythema, itching, flaking, swelling, and even mucosal erosion, which significantly affected the patients’ quality of life and required prompt intervention. Diagnoses: Based on the clinical presentation and histopathological examination of the skin, the diagnoses included eczema and severe drug rashes such as toxic epidermal necrolysis and Stevens–Johnson syndrome. The incubation periods of the rashes ranged from 1 week to 2 months, and some patients also exhibited other symptoms like elevated white blood cell count, eosinophilia, increased C-reactive protein and lactate dehydrogenase levels, lymph node enlargement, fever, liver damage, and nail dystrophy. Interventions: All patients discontinued the use of apalutamide. They were treated with oral antihistamines and topical glucocorticoid ointment. Three cases received systemic glucocorticoid therapy, and 1 case was administered Duplizumab. The treatment strategies were adjusted according to the severity and progression of the rashes. Outcomes: The rashes gradually improved after the discontinuation of apalutamide and the initiation of appropriate treatment. In one case, the rash reappeared after the patient self-administered apalutamide again, but it subsided on its own after discontinuation of the drug. The symptoms of the other patients were well controlled, and no significant complications were observed during the follow-up period. Lessons: This case report highlights the importance of recognizing and managing apalutamide-associated skin AEs. The development of these AEs appears to be dose-dependent, and early discontinuation or dose reduction of the drug is crucial for controlling the symptoms. A multidisciplinary approach involving oncologists and dermatologists is recommended to optimize the treatment strategy and maintain the patients’ quality of life.


  • Open Access

    The relationship between smoking and rosacea: A Mendelian randomization study

    by YuJia Cai, HaiFeng Zeng, MaoCan Tao

    Background: Rosacea can be seen in many patients nowadays, and the related causes are complex. Despite a certain association between smoking and rosacea being reported by several studies, the actual causality has not been established for the possible bias and confounders. Methods: We used Mendelian randomization (MR) to evaluate a potential causal effect of smoking on rosacea risk. Statistics on smoking and rosacea were obtained from the FinnGen project and Neale Lab Consortium. The causal association was assessed by multiple methods including inverse variance weighted (IVW), MR Egger, weighted median, and weighted mode. Furthermore, sensitivity analyses were also conducted to address pleiotropy, along with the leave‐one‐out method.R version 4.2.3 was applied for the analyses. Results: The IVW estimation revealed that previous smoking has a deleterious effect on rosacea (odds ratio [OR] = 6.7729, 95% confidence interval [CI] = 1.5691–29.2356, p = 0.0104). By contrast, there was no statistically relationship between current smokers and rosacea (OR = 0.6180, 95% CI = 0.0605–6.3094, p = 0.6847). Results were similar in the analysis based on the weighted median method (previous smoking: OR = 8.6297, 95% CI = 1.0131–73.5071, p = 0.0486; current smoking: OR = 0.2896, 95% CI = 0.0106–7.9132, p = 0.4627). The stability of the causal effect estimates was supported by several sensitivity analyses and the leave‐one‐out method. Conclusion: Our MR study found support forrosacea risk and previous smoking. Although no evidence was found to increase the risk of rosacea in current smokers, to prevent various diseases associated with smoking, the public should be encouraged to avoid smoking at the very beginning.


  • Open Access

    Efficacy and safety of CO 2 fractional laser versus Er: YAG fractional laser in the treatment of atrophic acne scar: A meta‐analysis and systematic review

    by Fei Liu, Qiujun Zhou, Maocan Tao, Luying Shu, Yi Cao

    Background: To date, a consensus on the relative efficacy and safety of CO 2 fractional laser versus erbium‐doped yttrium aluminum garnet (Er:YAG) fractional laser treatments for atrophic acne scars has not been reached. This meta‐analysis aims to systematically assess and compare their effectiveness and safety in clinical practice. Methods: For this meta‐analysis, we conducted comprehensive searches in Pubmed, Embase, and Cochrane databases, covering publications from their inception up to August 2023. Our focus was on studies comparing fractional CO 2 laser with Er:YAG fractional laser treatments for atrophic acne scars. We excluded duplicate publications, research lacking full‐text access, incomplete data, or cases where data extraction was not feasible. Additionally, animal experiments, reviews, and systematic reviews were not considered. Data analysis was performed using STATA 15.1. Results: Eight studies (seven randomized controlled trials (RCTs) and a retrospective study) were included in this meta‐analysis. The sample size ranged from 28 to 106 with a total of 418 patients, including 210 in the CO 2 fractional group and 208 in Er:YAG fractional group. The pooled results showed that the effective rate of CO 2 fractional laser in treating atrophic acne scar was significantly higher than that of Er:YAG fractional laser (OR = 1.81, 95% CI: 1.08–3.01) and the downtime of CO 2 fractional laser in treating atrophic acne scar was significantly shorter than that of Er:YAG fractional laser (Weighted Mean Difference (WMD) = −2.11, 95% CI: −3.11 to −1.10). In addition, VAS of CO 2 fractional laser in treating atrophic acne scar was significantly higher than that of Er:YAG fractional laser (WMD = 1.77, 95% CI: 1.32–2.21) and the duration of erythema of CO 2 fractional laser in treating atrophic acne scar was significantly longer than that of Er:YAG fractional laser (WMD = 1.85, 95% CI: 1.63–2.07). However, there was no significant difference in the duration of pain and incidence of PIHbetween CO 2 fractional laser and of Er:YAG fractional laser. Conclusion: When it comes to treating atrophic acne scars, CO 2 fractional laser demonstrates superior efficacy and leads to shorter downtime. However, it is important to note that CO 2 fractional laser treatments tend to result in higher pain intensity and may carry a higher risk of post‐treatment pigmentation compared to Er:YAG fractional laser procedures.


  • Open Access

    Effect of fire needle combined with traditional Chinese medicine on psoriasis: A systematic review and meta-analysis

    by Jinglun Xu, Qiujun Zhou, Fan Xie, Yi Cao, Xiaohong Yang, Maocan Tao

    Background: The mechanism of action of fire acupuncture and Chinese medicine in psoriasis is unclear. In this paper, the efficacy of the 2 therapies was compared through a comprehensive analysis of their recurrence rates for clinical reference. Methods: In this meta-analysis, we searched PubMed, Embase, Cochrane Library, CNKI, Wanfang, CQVIP, and CBM data from the establishment of the databases to May 2023. The study proposed to use randomized controlled trial research methods, excluding published literature, unpublished literature, literature with incomplete or inadequate information, animal experiments, literature reviews and systematic studies. Data were processed using STATA 15.1 software. Results: Our group previous study found that the clinical efficacy of the fire-acupuncture group was significantly improved compared to that of Chinese herbal medicine alone (RR = 1.20, 95% CI: 1.13–1.27). Also, there were significant reductions in Psoriasis Area and Severity Index (PASI) score (SMD = −1.04,95% CI: −1.48 to −0.60), area of skin damage (SMD = −0.40,95% CI: −0.75 to −0.04), and pruritus (SMD = −1.04,95% CI: −1.32 to −0.76). Our previous study found that Dermatology Life Quality Index (DLQI) was significantly lower in the fire acupuncture group compared to herbal medicine alone (SMD = −1.61,95% CI: −3.08 to −0.15). The combined analysis found that the recurrence rate was significantly lower in the fire-acupuncture group compared to herbal medicine alone (RR = 0.21,95% CI:0.07–0.60). Conclusion: Fire needle can improve the efficacy of TCM in the treatment of psoriasis, including the area, severity and itching of skin lesions, and reduce the recurrence rate, which is worthy of clinical promotion.


  • Zerumbone attenuates the excessive proliferation of keratinocytes in psoriasis mice through regulating NLRP3/NF-κB pathway

    by Jin Lin, Yimiao Fang, Yi Cao, Lili Ma, Maocan Tao, Xiao Wang, Yuanyuan Li, Lijun Qing

    Psoriasis is a common chronic disease, and existing treatment regimens often exhibit certain toxicities and side effects. Zerumbone (Zer) may possess therapeutic effect, and the objective of this study is to investigate the effect of Zer on psoriasis. A mouse model of psoriasis was established using imiquimod cream, and the role of Zer on the pathological alterations in psoriatic mouse skin was evaluated by psoriasis area and severity index (PASI) score; the effect of Zer on keratinocyte proliferation was evaluated via hematoxylin and eosin staining, Zen image analysis, and immunofluorescence; Immunohistochemistry and enzyme-linked immunoassay were used to evaluate the effect of Zer on tissue inflammatory responses, while malondialdehyde (MDA) and glutathione (GSH) levels were measured to elucidate the role of Zer in modulating oxidative stress; the signaling pathway regulated by Zer was evaluated by western blotting. The results demonstrated that Zer could alleviate the pathological manifestations of psoriasis, reduce PASI score, reduce skin pathological damage and epidermal hyperplasia, diminish the number of CD8+ T cells and cytokine expression levels, decrease the level of MDA and GSH and increase the expression of Nrf and HO-1. Zer was found to regulate the NLRP3/nuclear factor-kappa B (NF-κB) signaling pathway. In conclusion, Zer ameliorated the symptoms of psoriasis in mice, suppressed the keratinocyte hyperproliferation, and mitigates inflammation and oxidative stress in psoriatic skin tissue by regulating the NLRP3/NF-κB pathway.


  • Open Access

    Caizhixuan hair tonic regulates both apoptosis and the PI3K/Akt pathway to treat androgenetic alopecia

    by Tingting Fang, Ruofei Xu, Shaopeng Sun, Yineng He, Yi Yan, Hongyang Fu, Hongbin Luo, Yi Cao, Maocan Tao

    Purpose: Caizhixuan hair tonic (CZX) is a topical traditional Chinese medicine (TCM) preparation for the treatment of androgenetic alopecia (AGA). However, its active compounds and underlying mechanism for treating AGA are still unclear. The purpose of this study was to observe the effects of CZX on hair growth promotion in AGA mice and to explore the active components and mechanism. Methods: Testosterone propionate was administered subcutaneously to mice to establish an AGA mouse model. The therapeutic effects of CZX on AGA were evaluated by observing skin colour changes, hair growth time, and average hair length; calculating the hair growth score; and performing skin histopathological analysis. Following that, CZX chemical components were analysed by ultra-high-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry (UPLC–Q–TOF/MS). Network pharmacology was used to predict the major effects and possible mechanisms of CZX for the treatment of AGA. Furthermore, RT-qPCR and Western blotting were performed to assess the expression of key genes and proteins involved in PI3K/Akt and apoptosis pathways in order to validate CZX’s predicted mechanism in AGA. Results: CZX promoted hair growth and improved the pathological morphology of hair follicles in the skin. In UPLC–Q–TOF/MS analysis, 69 components from CZX were isolated. Based on network pharmacology, CZX alleviated AGA by regulating PI3K/Akt and apoptosis pathways. According to RT-qPCR and Western blotting, CZX upregulated the expressions of PI3K, Akt, and Bcl-2, while downregulating that of Bax and caspase-3. Conclusions: CZX promotes hair growth to treat AGA by regulating the PI3K/Akt and apoptosis pathways.


  • Open Access

    Macrophages in melanoma: A double‑edged sword and targeted therapy strategies (Review)

    by Qiujun Zhou, Tingting Fang, Shenyu Wei, Shiqian Chai, Huifeng Yang, Maocan Tao, Yi Cao

    Melanoma, which evolves from melanocytes, is the most malignant skin cancer and is highly fatal, although it only accounts for 4% of all skin cancers. Numerous studies have demonstrated that melanoma has a large tumor mutational burden, which means that melanoma has great potential to achieve immune evasion. Tumor‑associated macrophages (TAMs) are an important component of both the immune system and tumor microenvironment. Several studies have demonstrated their double‑edged sword effects on melanoma. The present review focuses on the role of TAMs in melanoma development, including regulation of proliferation, invasion, metastasis, angiogenesis and chemical resistance of melanoma. Furthermore, the existing mechanisms of action of the TAM‑targeting treatments for melanoma are reviewed. More broadly, the weak points of existing research and the direction of future research are finally identified and described.


  • Open Access

    Acupuncture and moxibustion combined with cupping for the treatment of post-herpetic neuralgia

    by Qiujun Zhou, Shenyu Wei, Haijia Zhu, Yue Hu, Yong Liu, Huifeng Yang, Shicheng Zeng, Shiqian Chai, Jingyuan Li, Maocan Tao

    Background: There are still controversies between the curative effect of acupuncture combined with cupping therapy and western medicine for post-herpetic neuralgia (PHN). Our meta-analysis fully incorporates the research of acupuncture combined with cupping therapy versus Western medicine for PHN, aiming to explore the difference in the efficacy of the 2 therapies, so as to provide guidance for clinical treatment. Methods: We searched PubMed, Embase, Cochrane Library, CNKI, Wanfang, CQVIP, CBM, from establishment of the database to September, 2020. Include studies that are clearly defined as PHN or herpes zoster, and exclude duplicate publications; studies with no full text, incomplete information, or inability to extract data; the definition of exposure is quite different from most literature; animal experiments. Results: The total effective rate (relative ratio [RR] = 1.21, 95% confidence interval [CI]: 1.12–1.31) and the rate of remarkable effect (RR = 1.46, 95% CI: 1.30–1.63) of acupuncture and moxibustion combined with cupping in the treatment of PHN were significantly higher than that of conventional western medicine. The visual analogue scale score of acupuncture and moxibustion combined with cupping for PHN was significantly lower than that of conventional western medicine treatment (WMD = –1.77, 95% CI [–2.79, –0.75]). In addition, acupuncture and moxibustion combined with cupping therapy significantly reduced the occurrence of PHN compared with conventional western medicine treatment after treatment of acute herpes zoster (RR = 0.30, 95% CI: 0.20–0.45). In order to explore the differences in the efficacy and preventive effects of different types of acupuncture and cupping therapy, we have further conducted a subgroup analysis. Conclusion: The effect of acupuncture and moxibustion combined with cupping in the treatment of PHN is significantly higher than that of conventional western medicine, and it can significantly prevent the occurrence of PHN. Chinese medicine should be used more widely in the treatment of PHN.